Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (931-940 of 1,212) with videos related to

Pageof 122
Sort By:
Cancer|June 5, 2003
Cancer incidence in the US radiologic technologists health study, 1983-1998Alice J Sigurdson, Michele Morin Doody, R Sowmya Rao, et al.
The American Journal of Medicine|July 26, 2017
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE TrialChiara Melloni, Allison Dunning, Christopher B Granger, et al.
American Heart Journal|September 2, 2020
Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trialOliver K Jawitz, Morgan L Cox, David Ranney, et al.
Circulation|April 19, 2014
Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experienceAnthony W Castleberry, Judson B Williams, Mani A Daneshmand, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
The Annals of Thoracic Surgery|April 20, 2026
The Society of Thoracic Surgeons 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation after Cardiac SurgerySubhasis Chatterjee, Michael C Grant, Dawn S Hui, et al.
American Heart Journal|September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialShinya Goto, Jun Zhu, Lisheng Liu, et al.
American Heart Journal|October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarctionThomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.
Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
Pageof 122

Showing results (931-940 of 1,212) with videos related to

Sort By:
Pageof 122
Cancer|June 5, 2003
Cancer incidence in the US radiologic technologists health study, 1983-1998Alice J Sigurdson, Michele Morin Doody, R Sowmya Rao, et al.
The American Journal of Medicine|July 26, 2017
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE TrialChiara Melloni, Allison Dunning, Christopher B Granger, et al.
American Heart Journal|September 2, 2020
Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trialOliver K Jawitz, Morgan L Cox, David Ranney, et al.
Circulation|April 19, 2014
Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experienceAnthony W Castleberry, Judson B Williams, Mani A Daneshmand, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
The Annals of Thoracic Surgery|April 20, 2026
The Society of Thoracic Surgeons 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation after Cardiac SurgerySubhasis Chatterjee, Michael C Grant, Dawn S Hui, et al.
American Heart Journal|September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialShinya Goto, Jun Zhu, Lisheng Liu, et al.
American Heart Journal|October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarctionThomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.
Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
Pageof 122